Diet and Lifestyle for Hypoglycemia (when combined) on Ozempic (semaglutide 0.5-2 mg): What Actually Works

At a glance

  • Ozempic alone, 30 weeks: no severe lows; documented symptomatic lows 1.6% at 0.5 mg and 3.8% at 1 mg vs 0% on placebo [1]
  • Ozempic added to basal insulin, 30 weeks: severe or blood-glucose-confirmed lows 10.7% on 1 mg vs 5.3% on placebo [1]
  • Sulfonylureas: the label says hypoglycemia was more frequent when Ozempic was combined with one [1]
  • What the label advises: consider reducing the insulin or sulfonylurea dose when starting Ozempic [1]
  • Meals: the injection goes in once weekly, at any time of day, with or without meals [1]

Where the risk comes from

The Ozempic label states that semaglutide stimulates insulin release when blood glucose is already elevated, and that people who take it with an insulin secretagogue such as a sulfonylurea, or with insulin, may have an increased risk of hypoglycemia, including severe hypoglycemia [1]. In the label's 30-week monotherapy trial nobody had a severe low [1].

The step the label describes is a drug adjustment, not a food rule: the risk may be lowered by a reduction in the dose of the sulfonylurea or other insulin secretagogue, or of insulin, and patients on those medicines should be told about the risk and taught the signs and symptoms of hypoglycemia [1].

What the trials showed

Two 30-week placebo-controlled trials in adults with type 2 diabetes are summarized in the label's hypoglycemia table [1].

Ozempic alone (129 placebo, 127 on 0.5 mg, 130 on 1 mg):

  • Severe hypoglycemia, an episode needing another person's help: 0% in all three groups [1]
  • Documented symptomatic low at or below 70 mg/dL: 0% on placebo, 1.6% on 0.5 mg, 3.8% on 1 mg [1]

Ozempic added to basal insulin, with or without metformin (132 placebo, 132 on 0.5 mg, 131 on 1 mg):

  • Severe hypoglycemia: 0% on placebo, 0% on 0.5 mg, 1.5% on 1 mg [1]
  • Documented symptomatic low at or below 70 mg/dL: 15.2% on placebo, 16.7% on 0.5 mg, 29.8% on 1 mg [1]
  • Severe or blood-glucose-confirmed symptomatic low at or below 56 mg/dL: 5.3% on placebo, 8.3% on 0.5 mg, 10.7% on 1 mg [1]

In the basal-insulin trial, documented symptomatic lows were more frequent with Ozempic than with placebo [1]. The label separately says hypoglycemia was more frequent when Ozempic was combined with a sulfonylurea [1].

Meals and insulin injections

The label says to give Ozempic once weekly, on the same day each week, at any time of day, with or without meals [1]. With insulin, the label says Ozempic and insulin are separate injections and must not be mixed; the same body region is acceptable, but the spots should not be adjacent [1].

Frequently asked questions

What happened when Ozempic was added to basal insulin?
In the 30-week basal insulin trial, severe or blood-glucose-confirmed symptomatic lows at or below 56 mg/dL occurred in 5.3% on placebo, 8.3% on Ozempic 0.5 mg and 10.7% on Ozempic 1 mg [1].
Does Ozempic need to be taken with a meal?
No. The label says to give it once weekly, on the same day each week, at any time of day, with or without meals [1].
Can Ozempic and insulin be mixed in the same injection?
No. The label says they are separate injections that must not be mixed; injecting both in the same body region is acceptable, but the spots should not be adjacent [1].

References

  1. U.S. National Library of Medicine, DailyMed. Ozempic injection (Novo Nordisk) prescribing information. Ozempic injection (Novo Nordisk) label
Evidence overview for Diet and Lifestyle for Hypoglycemia (when combined) on Ozempic (semaglutide 0.5-2 mg): What Actually Works